Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Pacira BioSciences (PCRX.US)$$Flexion Therapeutics (FLXN.US...

$Pacira BioSciences (PCRX.US)$ $Flexion Therapeutics (FLXN.US)$ On October 12, Pacira BioSciences announced that it has entered into a definitive agreement to acquire Flexion Therapeutics For $8.50 per share, or approximately $430 million, in cash to enhance its non-opioid pain portfolio. The deal also includes contingent valuable rights worth up to $8.00 per share, which are tied to Zilretta sales targets and FDA approvals for FX201 and FX301.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
3
+0
Translate
Report
13K Views
Comment
Sign in to post a comment